Medipattern Announces Stock Option Grant
March 15 2011 - 10:15PM
Marketwired
Attention: Business/Financial Editors
The Medipattern Corporation ("Medipattern" or the "Company")
(TSX VENTURE: MKI), a pioneer in the development of medical
software solutions that help improve imaging workflow and
productivity, announced that on March 14, 2011, in accordance with
its stock option plan, the board of directors of Medipattern
approved the grant of an aggregate of 100,000 incentive stock
options to a director and officer of the Company. The options are
exercisable on or before March 14, 2016 at an exercise price of
$0.40 per share.
About The Medipattern Corporation:
Medipattern® is a pioneer in the development of imaging software
solutions that help medical practitioners better understand lesions
and critical anatomy. Medipattern uses its Cadenza™ Algorithm
Technology to power Visualize:Vascular™ 3D reconstruction of areas
of interest within the vessel as well as our first-to-market,
award-winning B-CAD® advanced breast ultrasound computer aided
detection (CAD). For more information, please visit the Company's
website at: www.medipattern.com.
B-CAD® and Medipattern® are registered marks of The Medipattern
Corporation. Visualize:Vascular™ and Cadenza™ are trademarks of The
Medipattern Corporation.
Forward-looking statements
This document contains forward-looking statements relating to
Medipattern's performance, operations, or business environment.
These statements are based on what we believe are reasonable
assumptions given currently available information and our
understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements
using words such as "anticipates," "believes," "estimates,"
"expects," "plans," "intends," "potential", and similar
expressions. Forward-looking statements are not guarantees of
future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause
actual outcomes and results to differ materially from those
expressed in forward-looking statements. These factors include but
are not limited to those set forth in the Company's corporate
filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are
made. The Company disclaims any intention or obligation to update
or revise any forward-looking statements for any reason. Readers
should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: The Medipattern Corporation Jeff Collins CEO (416)
744-0009 ext. 224 jcollins@medipattern.com Spinnaker Capital
Markets Inc. Kevin O'Connor (416) 962-3300 ext. 226
ko@spinnakercmi.com
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jun 2024 to Jul 2024
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jul 2023 to Jul 2024